| abstract |
The problem to be solved by the present invention is to provide a method for identifying a patient with malignant tumor which can be expected to benefit more from an immune checkpoint inhibitor, and agent for suppressing the progression of, suppressing the recurrence of, and/or treating malignant tumor, being prescribed based thereon.The present invention provides agents for suppressing the progression of, suppressing the recurrence of, and/or treating malignant tumor, being prescribed based on identifying a patient with malignant tumor which can be expected to benefit more from the immune checkpoint inhibitor, based on combination of two sets of evaluation items and specific condition defined by each of combination thereof. |